The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.

frequentistSSDBinary: Screened Selection Design with Binary Endpoints

A study based on the screened selection design (SSD) is an exploratory phase II randomized trial with two or more arms but without concurrent control. The primary aim of the SSD trial is to pick a desirable treatment arm (e.g., in terms of the response rate) to recommend to the subsequent randomized phase IIb (with the concurrent control) or phase III. The proposed designs can “partially” control or provide the empirical type I error/false positive rate by an optimal algorithm (implemented by the optimal_2arm_binary() or optimal_3arm_binary() function) for each arm. All the design needed components (sample size, operating characteristics) are supported.

Version: 0.1.0
Depends: mvtnorm, clinfun, ph2mult
Published: 2024-06-26
DOI: 10.32614/CRAN.package.frequentistSSDBinary
Author: Chia-Wei Hsu [aut, cre], Zongheng Cai [aut], Haitao Pan [aut]
Maintainer: Chia-Wei Hsu <Chia-Wei.Hsu at stjude.org>
License: GPL-2
NeedsCompilation: no
CRAN checks: frequentistSSDBinary results

Documentation:

Reference manual: frequentistSSDBinary.pdf

Downloads:

Package source: frequentistSSDBinary_0.1.0.tar.gz
Windows binaries: r-devel: frequentistSSDBinary_0.1.0.zip, r-release: frequentistSSDBinary_0.1.0.zip, r-oldrel: frequentistSSDBinary_0.1.0.zip
macOS binaries: r-release (arm64): frequentistSSDBinary_0.1.0.tgz, r-oldrel (arm64): frequentistSSDBinary_0.1.0.tgz, r-release (x86_64): frequentistSSDBinary_0.1.0.tgz, r-oldrel (x86_64): frequentistSSDBinary_0.1.0.tgz

Linking:

Please use the canonical form https://CRAN.R-project.org/package=frequentistSSDBinary to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.